INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Inspire Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$70.15+1.36 (+1.98%)
Close on Oct 19, 2026
- Market cap
- $2.03B
- P/E (TTM)
- 15.2
- Dividend yield
- –
Inspire Medical Systems, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $187.30M | $195.60M | $256.94M | $214.39M | $207.15M | $193.61M | $231.63M | $195.83M | $187.81M | $155.77M | $189.43M | $147.51M | 93.4% | -9.6% |
| International | $13.28M | $8.98M | $12.14M | $10.11M | $9.94M | $7.71M | $8.09M | $7.36M | $8.08M | $8.24M | $3.08M | $5.79M | 6.6% | +33.6% |
From the segment and revenue-disaggregation notes of Inspire Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.